Key facts
- It has raised $279.9M across 7 recorded rounds; the latest was Later Stage VC (Series G) ($85.0M) in Jun 2021.
- 5 institutional filers report fund marks on PROCEPT BioRobotics across 24 filings.
- PROCEPT BioRobotics has filed 8 Form Ds with the SEC since 2013, most recently Jun 2021 ($85.0M sold to 50 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 7 rounds
- ·Watchlist + deal alerts for PROCEPT BioRobotics
Create free account
No card required
Funding rounds
7 roundsJun 2021Later Stage VC (Series G)$85.0M▮
Aug 2020Later Stage VC (Series F)$77.0M▮
Feb 2018Later Stage VC (Series E)$118.0M▮
About PROCEPT BioRobotics
- Industry
- Surgical Devices
PA Mark — not yet priced
PROCEPT BioRobotics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in PROCEPT BioRobotics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
5 filers · latest Jan 20265 SEC-registered funds reported 24 fair-value marks on PROCEPT BioRobotics between Apr 2025 and Jan 2026. Filer-level marks and implied $/share are available to Pro members.